Vitamin C may fight cancer — but not the way scientists once thought

Linus Pauling was widely mocked for claiming that vitamin C could fight cancer, especially after trials using vitamin C pills showed no benefit. Researchers now know that intravenous vitamin C reaches vastly higher concentrations and can behave more like an experimental cancer drug than an ordinary supplement. Early studies suggest it may damage vulnerable cancer cells, reduce treatment side effects, and possibly improve outcomes for some patients. These findings highlight the importance of reevaluating the potential of nutrients like vitamin C in cancer treatment. However, it is essential to note that more research is needed to fully understand the effects of intravenous vitamin C on cancer. This paper does not provide medical advice or a recommendation for treatment. Further studies will be necessary to determine the efficacy and safety of intravenous vitamin C in cancer patients. Researchers should approach these results with caution, considering the limitations of the current evidence and the need for rigorous testing in clinical trials. Additionally, it is crucial to recognize that the results of these studies should not be used to replace established treatments, but rather to inform and potentially augment them. The study of nutrient-based interventions in cancer treatment is an active area of research, and this paper aims to contribute to the ongoing discussion of this topic. The implications of this research will depend on the results of future studies, which will be necessary to confirm or refute the findings reported here.